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Abstract 
Background: Stigma resistance, one’s ability to block the internalization of stigma, appears to 
be a key domain of recovery. However, the conditions in which one is most likely to resist 
stigma have not been identified, and models of stigma resistance have yet to incorporate one’s 
ability to consider the mind of others. The present study investigated the impact of the interaction 
between metacognition, or one’s ability to form an integrated representation of oneself, others, 
and the world, and fear of negative evaluation on one’s ability to resist stigma.  
 
Methods: Narratives of encounters with stigma shared by 41 persons with schizophrenia or 
schizoaffective disorders were first coded for spontaneous expressions of fear of negative 
evaluation from others. Two-step cluster analyses were then conducted in order to test the 
hypothesis that metacognition and fearing negative evaluation from others are important, 
interacting pathways which contribute to resisting stigma. 
 
Results: Those with high (n = 11; 26.8%), intermediate (n = 9; 22.0%), and low metacognition 
(n = 21; 51.2%) significantly differed on stigma resistance (F = 9.49, p < .001) and the high 
metacognition group was most likely to resist stigma. Those with high and low metacognition 
did not express fear of negative evaluation, while those with intermediate metacognition did 
express fear of negative evaluation.  
 
Discussion: Findings suggest that metacognition and fear of negative evaluation are important, 
interacting pathways influencing how individuals process and respond to stigma.  
 
Limitations: These results are based on a relatively small, cross-sectional sample; findings 
should be replicated in a larger sample using a longitudinal design.  
 
Conclusions: Results offer preliminary support for this novel model of stigma resistance and 
support the use of metacognitive therapies for facilitating stigma resistance.  
 
Keywords: stigma, metacognition, schizophrenia, fear of negative evaluation  
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 Stigma, the negative attitudes, beliefs, and actions toward those with mental illness, is 
frequently implicated in factors that hinder recovery for persons with mental illness, including 
discrimination in the workplace, differential treatment in the criminal justice system, increased 
barriers toward treatment seeking, and even the perpetuation of stigmatizing attitudes by mental 
health providers [1, 2, 3, 4]. Given the high prevalence of public stigma [2], a consequence for 
some individuals with mental illness can be self-stigma, the internalization of the negative beliefs 
and attitudes about mental illness [5]. Internalizing stigma has been conceptualized to involve 
awareness of public stigma, agreement with these negative attitudes and beliefs, and application 
of stigma to oneself [6, 7]. Moreover, internalizing stigma has been associated with poor 
outcomes regarding symptoms, empowerment, self-esteem, hope, and recovery beliefs among 
those with mental illness, and the relationships between having insight into having an illness and 
recovery outcomes are moderated by one’s level of internalized stigma [8, 9].  
The conditions that facilitate effectively resisting stigma have yet to be identified [10]. 
Indeed, not all individuals with a mental illness internalize public stigma attitudes and awareness 
of stigma can, at times, produce “righteous anger” or responses that are less strongly linked to 
decreases in self-esteem or self-efficacy [11, 12, 13]. After testing several models of internalized 
stigma, Drapalski et al. (2013) concluded that multiple pathways exist between internalized 
stigma and outcomes among persons with severe mental illness and that treatments should be 
multifaceted in their approach to helping people resist stigma [14]. Relatively little work to date, 
however, has examined the factors that impact how one resists stigma and factors that might be 
protective.  
Accordingly, we propose a model of stigma resistance that accounts for two 
psychological factors that have been largely overlooked in the stigma literature to date: 
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metacognition and fear of negative evaluation. First, metacognition refers to one’s ability to form 
an integrated representation of oneself, others, and the world and integrate that information in a 
way that allows a person to respond to psychological or social challenges [15]. Evidence 
suggests that metacognition plays an important role in functioning for persons with mental 
illness [16, 17, 18] and also may be a factor underlying how individuals perceive and respond to 
stigma. For instance, Nabors et al. [19] found that metacognition significantly predicted one’s 
ability to resist stigma, even after controlling for symptoms and the degree to which one agreed 
with stereotypes about mental illness. 
A second, related factor that may influence whether one resists or internalizes stigma is 
fear of negative evaluation from others -- one’s “apprehension about others’ evaluations, distress 
over their negative evaluations, and the expectation that others would evaluate oneself 
negatively” [20, p. 448]. Cognitive-behavioral models conceptualize fear of negative evaluation 
as central to social anxiety and associations have been found between fear of negative evaluation 
and lower self-esteem and fewer expectancies for success [21, 22, 23]. Given the impact that fear 
of unfavorable evaluations appears to have in the context of social anxiety, and that public 
stigma regarding mental illness often directly includes negative assumptions about likelihood of 
success [3], it seems likely that fears regarding negative evaluation may also be a type of 
response to stigma. Furthermore, it seems likely that deficits in one’s ability to take the 
perspective of another into account would impact whether or not one fears negative evaluation in 
the context of stigma and, moreover, whether one experiences the negative outcomes often 
associated with stigma.  
The current study builds on previous work by proposing a model of stigma resistance that 
accounts for the degree to which one considers the minds of others in an appraisal of stigma. We 
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examined metacognition and fear of negative evaluation as distinct, but interacting pathways, 
hypothesizing that participants would differ on stigma resistance depending on their profile 
regarding levels of metacognition and fear of negative evaluation of others. Specifically, we 
hypothesized that we would see individuals differ in their levels of metacognition and that 
responses regarding fear of negative evaluation would have a curvilinear relationship (i.e., 
highest and lowest metacognition would be associated with low fear of negative evaluation and 
intermediate metacognition would be associated with greater fear of negative evaluation). We 
further hypothesized that we would see group differences in stigma resistance, with those with 
high metacognition better able to engage in stigma resistance than those with lower levels of 
metacognition.  
Methods 
Participants 
 Data were obtained as part of baseline assessments for a randomized controlled trial of 
Illness Management and Recovery (IMR; [25]) and from semi-structured interviews with a 
subsample of those participants prior to any intervention. Participants with schizophrenia or 
schizoaffective disorders, confirmed by a structured clinical interview (SCID; [24]), were 
recruited from an urban, Midwestern VA Medical Center (N=18) and Community Mental Health 
Center (N=28) and received $20 for completing the assessment and an additional $20 for the 
interview portion. IRB approval was obtained, and all participants were consented prior to the 
start of the study. Originally, 46 individuals were interviewed at baseline, among which 41 
participants shared encounters with stigma. For the purposes of our research questions for this 
study, we examined only narratives in which participants spontaneously discussed stigma. 
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Participants were primarily male (n=35, 76.1%) and Black (n =29,63.0%) and had a mean age of 
48.7 (8.7). 
Measures 
 Metacognition was measured using the Metacognition Assessment Scale (MAS-A; [26]), 
a rating scale created to detect the ability of a person with mental illness to think about their own 
thinking, the thinking of others, to recognize that one is not the center of the world, and to use 
that knowledge to solve psychological problems. The MAS-A was scored by trained raters.  We 
used a total score where higher scores indicated greater metacognitive capacity; inter-rater 
reliability in our sample was good (r=0.91). 
 Fear of negative evaluation was coded in qualitative descriptions of encounters with 
stigma shared by participants as part of a semi-structured interview, the Indiana Psychiatric 
Illness Interview (IPII; [27]). This tool has been widely used to elicit narratives regarding one’s 
perception of their illness and its impact on their life. Interviews lasted between 20 minutes and 4 
hours (with one participant going into much detail regarding their life story and taking several 
breaks). Consensus was reached among researchers regarding the presence or absence of this 
code in each participant transcript.  
Symptoms were assessed using the total score of the Positive and Negative Syndrome 
Scale (PANSS; [28]), an interview-based rating of symptoms across five domains: positive 
symptoms, negative symptoms, cognitive symptoms, hostility symptoms, and emotional 
discomfort symptoms [29]. Prior to conducting interviews, raters were trained to an inter-rater 
reliability of least .80. The reliability of the PANSS in our sample was good (α =.88).  
 Stigma Resistance was assessed using the Stigma Resistance sub-scale of the 
Internalized Stigma of Mental Illness Scale (ISMI; [30]), which has been widely used among 
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persons with severe mental illness. As documented elsewhere [31, 32] the stigma resistance sub-
scale shows distinct psychometric properties from the other subscales of the ISMI and has shown 
evidence of being a distinct construct [33, 34]. The sub-scale had adequate reliability (α=.58), 
which is consistent with the reliability of this subscale in other samples [30, 35].  
Analyses 
Analyses were conducted in five steps. First, we used directed content analysis [36] to 
examine sections of text where participants discussed encounters with stigma as part of their life 
narrative (IPII) for instances where participants expressed fear of negative evaluation from 
others. Coding was conducted using a team approach where multiple coders (blind to 
metacognition scores) read each description of an encounter with stigma and came to consensus 
to determine whether fear of negative evaluation was present. Transcripts and coding were 
organized using Atlas TI qualitative software. Second, we conducted two-step cluster analyses in 
order to test whether levels of metacognition and fear of negative evaluation influence stigma 
resistance. A two-step cluster analysis approach was selected because it identifies groupings of 
participants by accounting for continuous and categorical data, dividing the sample into groups 
that reflect low within group heterogeneity but high between group heterogeneity [37]. Next, we 
used t-tests and Chi-square tests to assess for group differences on background characteristics 
and symptoms. Controlling for any significant differences, we then examined group differences 
on stigma resistance using an ANOVA (or ANCOVA). Finally, if significant group differences 
were found on stigma resistance, we planned to conduct Tukey HSD Post-hoc analyses. 
Quantitative analyses were conducted in SPSS version 23.  
 
 
Metacognition and Stigma Resistance     8 
 
Results 
Using participants’ metacognition and fear of negative evaluation responses, we 
conducted two-step cluster analyses. This approach produced three distinct groups in our sample 
with an overall model quality that was >.075 on a 0-1.0 scale. We next generated labels that 
reference the properties of each group: 1) those with high metacognition who did not express 
fear of negative evaluation (n=11, 26.8%), 2) those with intermediate metacognition who did 
express fear of negative evaluation (n=9, 22.0%), and 3) those with low metacognition who did 
not express fear of negative evaluation (n=21, 51.2%). High and low cut-points for 
metacognition were determined using a median split (10.5) and the mean scores for each group 
are reported in Table 1. Demographic variables and overall symptoms were compared across the 
three groups (see Table 2), revealing no significant differences. 
Next, we tested for group differences on stigma resistance. Significant group differences 
were found between groups (F = 9.49, p < .001) and Tukey HSD follow-up analyses revealed 
that those with high metacognition endorsed significantly higher levels of stigma resistance than 
those with low metacognition (p <.001) and intermediate levels of metacognition (p <.001). 
Stigma resistance was not statistically different among those with intermediate and low levels of 
metacognition (p<.77).  
Discussion 
Here we proposed a novel model of stigma resistance, anticipating that levels of 
metacognition and fear of negative evaluation would account for differences in stigma resistance. 
Specifically, we hypothesized that individuals would range from high to intermediate to low 
metacognition and that fear of negative evaluation would differ accordingly, with those with 
greatest and lowest metacognition expressing less fear of negative evaluation and those with 
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intermediate levels of metacognition being more likely to express greater fear of negative 
evaluation. We then hypothesized that those with high metacognition would be more likely to be 
engaged in resisting stigma. Consistent with our hypotheses, we found three groups that varied 
by metacognition and our first hypothesis was supported (i.e., the group with high metacognition 
and no expressed fear of negative evaluation had the highest levels of stigma resistance 
compared to both those with intermediate and low metacognition).    
These findings offer preliminary support for an innovative model of stigma resistance 
that accounts for the factors of metacognition and fear of negative evaluation. Similarly, this 
study is the first to our knowledge to consider the combined impact of metacognition and fear of 
negative evaluation on whether one resists stigma. Results support our hypothesis that 
metacognition and fear of negative evaluation act as distinct, but interacting, factors that may 
contribute to stigma resistance. Further, those who appear most engaged in resisting stigma were 
those with high levels of metacognition who did not fear negative evaluation from others. While 
the correlational nature of our study precludes casual inferences, one possible explanation of 
these findings is that the high metacognition group is able to discern the minds of others and 
reject stigma (e.g., seeing them as separate and inaccurate beliefs). Alternatively, it is also 
possible that people who are better able to reject stigma are also better able to reflect the minds 
of others. Given the relationship between effectively resisting stigma and positive outcomes 
among persons with mental illness [32], the current findings shed light on two important factors 
that may influence whether or not individuals resist stigma. Stigma resistance has been largely 
under-studied, and conditions under which individuals are most likely to resist stigma have yet to 
be identified [10]. Our findings also support the conclusion that metacognition and fear of 
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negative evaluation may be important contextual factors that could independent, although 
interacting, influences on one’s ability to resist stigma. 
Our findings are consistent with and extend previous work in several notable ways. First, 
our results are consistent with past work linking metacognitive capacity and increased stigma 
resistance [19]. Second, these findings link metacognition with fear of negative evaluation, 
which has previously been discussed primarily in the literature on dysfunctional beliefs and 
social anxiety [21, 22, 23]. Although we did not have a measure of anxiety in this study, stigma 
and self-stigma have been associated with higher levels of anxiety among persons with 
schizophrenia [16]. It is possible that those who are more anxious have a greater predisposition 
for fear of negative evaluation in the context of stigma and may be at greater risk for 
internalizing stigma. Finally, these findings also seem to suggest that a capacity to form complex 
ideas about the thoughts of others and oneself and use this information to address psychological 
problems may influence not only how one processes stigma but also whether one views stigma 
as valid. Using Watson, Corrigan, Laron, & Sell’s (2007) [7] model of self-stigma, 
metacognition may be one factor that assists individuals to differentiate between awareness of 
stigma and agreement or application of stigma to oneself. That is, the capacity to understand and 
differentiate the perspective of others from one’s own thoughts may be an important process that 
assists some individuals to not fear negative evaluation when they encounter stigma from others.   
While the current findings offer a novel perspective regarding factors that may help 
individuals with mental illness resist stigma, several limitations should be noted and addressed in 
future work. In the current study, we use verbalizations of fear of negative evaluation that 
participants spontaneously reported, and we may be missing important information and 
perspectives of those who did not bring up stigma and fear of negative evaluation. Given the lack 
Metacognition and Stigma Resistance     11 
 
of existing research in this area, this mixed-methods study provided an opportunity to explore 
fear of negative evaluation regarding stigma as it naturally emerged.  Future studies might 
examine fear of negative evaluation more directly and compare the present findings with 
participants who are directly asked about fear of negative evaluation. A second limitation was 
the relatively small sample size, particularly of individuals who expressed fear of negative 
evaluation. While it is notable that only twenty-two percent of the sample expressed fear of 
negative evaluation, this limited our ability to assess high and low levels of metacognition within 
this group, and future studies should investigate these interactions in larger samples. Finally, all 
participants were individuals engaged in treatment, and additional work should examine whether 
experiences with resisting stigma differ among those outside an intervention setting.  
Finally, these findings may have several important implications for practice and policy. 
Clinically, these findings support the use of metacognitive oriented interventions to develop an 
enriched understanding of oneself and others as a protective factor in responding to stigma [18, 
38]. For instance, it may also be that effectively resisting stigma involves developing the ability 
to differentiate negative evaluation by others from their own evaluation of themselves [39, 40]. 
These findings may also inform the development and refinement of interventions targeting 
greater stigma resistance, including support for focus on metacognitive capacity and cognitive 
beliefs.  Finally, these findings highlight the need for individualized intervention targeting stigma 
resistance. For instance, individuals with high or low metacognition did not express fear of 
negative evaluation, while those with medium metacognition levels did express fear of negative 
evaluation. This suggests that the same intervention may not be appropriate across groups, 
particularly if the moderate metacognition group is aware of negative appraisals from others, 
while the low metacognition group is not aware of these appraisals to the same degree. The 
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profiles observed also suggest that when targeting metacognition as a mechanism to improve 
stigma resistance, there may be a period when one grows in awareness of stigma and negative 
evaluation from others (e.g., moderate metacognition). This trend may be similar to those 
observed between improvement in insight into one’s illness and increases in both hopelessness 
and improved functioning associated with self-stigma [9].   
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Table 1. Groups Produced by Two-step Cluster Analysis 
 
Group  
 
n MAS 
Mean (SD) 
Fear of Negative 
Evaluation 
(1=present, 0=absent) 
High Metacognition 
Intermediate Metacognition 
11 
9 
16.55 (1.7) 
12.44 (2.9) 
0 
9 
Low Metacognition 21 10.43 (2.1) 0 
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Table 2. Group Differences  
 
 
Overall 
Sample 
(N=41) 
High 
Metacognition 
(n=11) 
Intermediate 
Metacognition 
(n =9) 
Low 
Metacognition 
(n =21) 
Statistical 
Significance 
Test 
Gender     0.29, p=.75 
   Male 31 9 6 16  
   Female 10 2 3 5  
Race     1.26, p=.30 
   African American 26 5 9 12  
   Caucasian 15 6 0 9  
Education    0.85, p=.44 
   Less than HS 15 3 4 8  
   HS or beyond 26 8 5 13  
Employment    1.40, p=.26 
   Paid employment 5 1 2 1  
   No paid employment 36 10 7 20  
Marital History    1.40, p=.26 
   Never married 15 7 2 6  
   Currently/previously married 25 4 7 15  
Age (Mean, SD) 
PANSS Total (Mean, SD) 
Stigma Resistance (Mean, SD) 
49.4 (7.8) 
69.3 (15.9) 
14.6 (2.2) 
48.5 (7.7) 
66.2 (17.3) 
3.3 (0.4) 
50.4 (5.4) 
78.3 (13.0) 
2.8 (0.3) 
49.4 (9.0) 
67.0 (15.4) 
2.9 (0.3) 
0.15, p=.86 
1.99, p=.15 
9.49, p=.001 
 
